| Analysis | Metabolite Name | Measured Value | Units | Gender:male | Glycemic status:diabetic | Neuropathy |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 1049430 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 1558782 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 2318525 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 2735655 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 2983165 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3137207 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4320724 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4341873 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4366741 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4450638 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4659748 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4888274 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 5288411 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 5376756 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 48636 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 53250 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 57288 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 125594 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 131060 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 135628 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 232815 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | 1517407 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | Peak area normalized | Neuropathy | |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | Peak area normalized | no neuropathy | |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | Peak area normalized | Neuropathy | |
| Reversed phase NEGATIVE ION MODE | URIDINE (M-H)- | Peak area normalized | Neuropathy | |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 1957 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 9483 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 10032 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 12352 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 14817 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 18808 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 19369 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 21748 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 23889 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 25613 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 32612 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 34821 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 37196 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 38605 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 20881 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 30124 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 34648 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 36416 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 42298 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 47799 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 50687 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 62091 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 68646 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 75973 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 79607 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 84362 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 91638 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 137353 | Peak area normalized | no neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|